← Eichor
Study identifier: NCT06680011 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis

Condition: Neurosyphilis · Biomarkers · Proteomics  ·  Sponsor: Shanghai Mental Health Center

PhaseN/A
Planned participants360
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The goal of this observational study is to identify diagnostic biomarkers for neurosyphilis in patients with the condition. The main questions it aims to answer are: What plasma biomarkers are associated with neurosyphilis? What electrophysiological characteristics (EEG and eye movement) are linked to neurosyphilis? Researchers will compare biomarker data from plasma and gut microbiome analyses with electrophysiological findings to see if these factors can help diagnose neurosyphilis. Participants will: Provide clinical information such as age, gender, symptoms, and disease course Submit blood and urine samples for proteomics and metagenomic sequencing Undergo EEG and eye movement evaluations for electrophysiological analysis

This description comes directly from the study's public registry record.

Talk to the study team

Xiaoyun Guo, PhD  ·  +86 13524600458  ·  xiaoyunguo@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Mental Health CenterShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06680011